However, DUSP26 has many other know downstream targets, such as TAK1 (28), FGFR1 (29), and FADD (17), understanding potential role of these targets in the anti-tumor effect of DUSP26 will need further studies. The gene discussed is FGFR1; the disease is neoplasm.